IP Library Granted Patent US 7,934,434
Granted Patent B2
US 7,934,434 · App. 11/948,249 · Granted May 3, 2011

Apparatus and method for analysis of dry powder inhaler products

Assignee: Pharmaceutical Product Development, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,934,434
App. No.
11/948,249
Granted
May 3, 2011
Kind
B2
Abstract

An apparatus and method are provided for collection and analysis of dry powder inhaler products to determine foreign particulate matter found therein. The apparatus includes a collection chamber that communicates directly with the mouthpiece of a dry powder inhaler device. The collection chamber is used to both collect product samples, as well as to mix the samples with a diluent that places the active pharmaceutical components and excipients in solution, while the foreign particulate matter remains suspended. Analysis of a sample is preferably conducted by light obscuration wherein a probe is inserted directly within the collection chamber of the apparatus. An integral magnetic stir-bar incorporated within the apparatus eliminates the need to transfer the collected sample to a secondary vessel for mixing or analysis.

Claims (18)

1. A particulate matter collection apparatus comprising:

a body defining a collection chamber therein;

a vacuum adapter removably connected to a first end of said body, said vacuum adapter having an orifice communicating with a vacuum source, and said vacuum adapter having a filter seat disposed therein;

a filter placed on said filter seat of said vacuum adapter;

an end cap removably connected to a second end of said body; and a stir-bar assembly mounted in said collection chamber, said stir-bar assembly including a rotatable magnetic stir-bar suspended in said collection chamber.

2. An apparatus, as claimed in claim 1 , wherein:

said collection chamber is cylindrical shaped.

3. An apparatus, as claimed in claim 1 , wherein:

said filter seat protrudes from a base of said vacuum adapter, said filter seat including an upper surface with a plurality of grooves formed thereon and communicating with said orifice thereby distributing a vacuum across said filter when said vacuum source is activated.

4. An apparatus, as claimed in claim 1 , wherein:

said second end of said body has a flange extending beyond said body to receive said end cap.

5. An apparatus, as claimed in claim 1 , wherein:

said stir-bar assembly further includes;

at least one support extending transversely across said chamber to mount said stir-bar assembly within said chamber;

a base secured to said support and said rotatable magnetic stir-bar extending from said base;

a pin mounted in said base and connected to said magnetic stir-bar thereby facilitating rotation of said magnetic stir-bar.

6. An apparatus, as claimed in claim 1 , wherein:

said magnetic stir-bar includes four stir-bar sections disposed in spaced relation to one another within said collection chamber.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2021
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Reel/Frame 058334/0093 →
RELEASE OF SECURITY INTEREST Recorded Jan 15, 2021
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
To: JAGUAR HOLDING COMPANY I; JAGUAR HOLDING COMPANY II; PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Reel/Frame 054931/0201 →
SECURITY INTEREST Recorded Jan 13, 2021
From: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 054902/0481 →
RELEASE OF SECURITY INTEREST Recorded Sep 2, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC; PPD DEVELOPMENT, L.P.; PHARMACO INVESTEMENTS, INC.; X-CHEM, INC.
Reel/Frame 036481/0051 →
SECURITY AGREEMENT Recorded Sep 2, 2015
From: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC; PPD DEVELOPMENT, L.P.; PHARMACO INVESTEMENTS, INC.; X-CHEM, INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 036528/0004 →
CONVERSION Recorded Feb 2, 2012
From: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.
To: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Reel/Frame 027647/0077 →
SECURITY AGREEMENT Recorded Dec 6, 2011
From: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.; PPD DEVELOPMENT, LP; PHARMACO INVESTMENTS INC. AND DUKE UNIVERSITY; PHARMACO INVESTMENTS INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 027334/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2007
From: SHELTON, CHRISTOPHER M.; STEPHENS, TIMOTHY J.
To: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.
Reel/Frame 020181/0678 →
Continuity (1)
Related Publication 20090139352A1 · Jun 4, 2009